Press release
E-Clinical Trial Solutions Market - Emerging Trends and New Technologies Research 2013 - 2019
Request Free Sample of Research Report: http://bit.ly/1WmiOc9
Conducting clinical trials for a novel drug requires efficient management of large amount of essential data with real-time analysis. Such management solutions improve efficiency, enhance the speed of clinical trials process, reduce clinical trial costs, and enable better data management and integration of different trial data for efficient observation.
E-clinical trial solutions market is segmented on the basis of technologies employed such as clinical trials management systems CTMS, electronic data capture (EDC) solutions, randomization and trial supply management system,electronic patient reported outcome (ePRO), interactive voice response systems (IVRS) and interactive response technology (IRT). These technologies are widely used in e-clinical trials solution systems. Similarly, geographically this market is segmented into North America, Europe, Asia-Pacific and rest of the world (RoW).
This market can be further segmented on basis of the end-users, namely, healthcare providers, clinical research organizations (CROs) and pharmaceutical companies. Increasing trend in outsourcing of clinical trial processes to CROs by pharmaceutical companies has led to an increase in the number of CROs globally.
China and India are the major destinations for clinical trial outsourcing due to availability of highly skilled labor force at lower cost and overall low cost of operations. Also, on the basis of the delivery mode the global e-clinical trial solutions market can be categorized into web hosted (on-demand), licensed enterprise (on premise) and cloud-based markets.
The major factors responsible for driving the growth of this market include technological advances in the field of e-clinical solutions, globalization of clinical trials and various benefits such as reduced cost of trials and increased efficiency and accuracy offered by e-clinical solutions. In the future, better, user-friendly access of software and awareness of compliance benefits will aid in increasing the acceptance and penetration of e-clinical solutions in the global market.
Browse Research Report: http://bit.ly/1T2ENOW
Some of the key players operating in this market include Oracle Health Sciences, BioClinica, eResearch Technology, Inc., Clinipace Worldwide,SAS Institute, Inc., MedidataSolutions, Datatrak International, Inc.and ParexelInternational Corporation.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release E-Clinical Trial Solutions Market - Emerging Trends and New Technologies Research 2013 - 2019 here
News-ID: 363128 • Views: …
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for CROs
Specialty Cros Market Is Booming So Rapidly 2025-2032 -CROs market include Charl …
The latest report (2025-2032) on the Specialty Cros Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/1627
Focused on growth and future opportunities,…
Specialty Cros Market Set to Witness Significant Growth by 2025-2032 | CROs mark …
Latest Qualitative Research Report on the Specialty Cros Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive research explores into the evolving Market's dynamics, value chain analysis, prominent investment areas, competitive landscape, drivers and constraints, regional outlook, and key market segments. It's also provides the industry overview with growth analysis and historical…
Global CROs Services Market Size - Forecasts to 2026
The findings reviewed by GME stated that the Global Contract Research Organization (CROs) Services Market will expand at a CAGR value of 9.62% to reach USD 85.61 billion by 2026 from USD 51.25 billion by 2021. The market is likely to be driven by the growing number of clinical testing, growing incidence of rare diseases, and rising investments in biopharmaceutical and pharmaceutical R&D activities.
Browse 155 Market Data Tables and 115…
Global CROs Services Market Insights, Forecast to 2025
Market Research Report Store offers a latest published report on CROs Services Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/435591/global-cros-services-market-insights
A contract research organization (CRO) is a company that…
CROS NT WINS A "BEST PRESENTATION" AT PhUSE 2010
Verona, Italy (26 NOVEMBER 2010) – Stefano Vezzoli, part of CROS NT’s highly qualified and experienced biostatistics team, won Best Presentation in the area of Statistics and Pharmacokinetics at the Pharmaceutical Users Software Exchange (PhUSE) conference in Berlin, Germany. Vezzoli’s presentation was titled “Inference for the Location Shift in 3x3 Crossover Studies: the Median-Scaling Method”.
Vezzoli’s Paper Abstract
In the case of non-normal study outcomes, a nonparametric approach may be used…
CROS NT appoints new Vice President for Germany
CROS NT (CRO) announces the appointment of Frank Freischläger as Vice President (VP) for CROS DE GmbH, the German affiliate of CROS NT. As a VP at CROS DE he will be responsible for all aspects, which is focused on successful clinical trial activities.
CROS is very excited to adding Mr. Freischläger's depth of industry expertise to the CROS team. "Bringing someone of Frank's knowledge to an already strong team…
